About Mainz Biomed (MYNZ)
Mainz Biomed N.V. is a Germany based molecular genetics cancer diagnostic company. The Company operates under one segment, namely genetic diagnostic testing services. Its portfolio consists of various products and product candidates, such as ColoAler... Read more
- USD3.70
- USD3.93
- USD3.35
- USD40.40
- -0.60%
- 1M
- 366.75k
- 269.64k
- 8M
- 2.65
- -89.70%
Stock News
yesterday
Meta’s blowout earnings show why investors shouldn’t sweat a boost to AI spending
MarketWatch
yesterday
Court finds Apple, executive lied under oath in Epic Games trial
CNBC
yesterday
Epic Systems expands EHR market share lead over Oracle Health
CNBC
yesterday
Meta’s Reality Labs posts $4.2 billion loss in first quarter
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
